Chackartchi T, Sachar Helft S, Findler M
Refuat Hapeh Vehashinayim (1993). 2014 Jan;31(1):43-9, 63.
Surgical intra-oral treatment for patients under antithrombotic therapy presents a challenge for the dental team. Within the last few years evidence based systematic reviews established new clinical guidelines for wide groups of patients which need to use antithrombotic treatment. The expected increase in use of antithrombotic treatment forced the pharmaceutical industry to provide new treatments. The former anticoagulant and anti-platelets aggregation groups of drugs were limited to small variety of medication. The search for the new treatments with ideal properties led to newly invented groups of drugs. In this article we will describe the new advancements in anti-thrombotic treatments. The article will summarize the limited knowledge of surgical management of patients under the new anti-thrombotic medications and the recommended approach for oral surgical procedures.
对于接受抗血栓治疗的患者,口腔内手术治疗对牙科团队来说是一项挑战。在过去几年中,基于证据的系统评价为需要使用抗血栓治疗的广泛患者群体制定了新的临床指南。抗血栓治疗使用量的预期增加促使制药行业提供新的治疗方法。以前的抗凝和抗血小板聚集药物类别仅限于少数几种药物。对具有理想特性的新治疗方法的探索导致了新发明的药物类别。在本文中,我们将描述抗血栓治疗的新进展。本文将总结关于接受新型抗血栓药物治疗的患者手术管理的有限知识以及口腔外科手术的推荐方法。